You are here

  • Home
  • Archive
  • Volume 9, Issue 1
  • Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts

Article metrics

Article menu
Basic tumor immunology
Original research
Differences in TCR repertoire and T cell activation underlie the divergent outcomes of antitumor immune responses in tumor-eradicating versus tumor-progressing hosts

 

Online download statistics by month:

Online download statistics by month: January 2021 to January 2026

AbstractFullPdf
Jan 202112641266456
Feb 2021430432142
Mar 2021240239102
Apr 202117317360
May 202133733745
Jun 202121621673
Jul 202122522572
Aug 202117417565
Sep 202120320385
Oct 2021243243101
Nov 202128728878
Dec 202134535367
Jan 202221322755
Feb 202212313846
Mar 202226928872
Apr 202218719770
May 202216416974
Jun 202221322579
Jul 202213714664
Aug 202220120962
Sep 202215316263
Oct 2022138148120
Nov 2022869145
Dec 2022868619
Jan 202312112464
Feb 202315315532
Mar 202315916453
Apr 20239910151
May 202311412034
Jun 202313513825
Jul 202314614854
Aug 2023848418
Sep 2023767719
Oct 202311311327
Nov 202310210429
Dec 2023636320
Jan 2024767827
Feb 2024818530
Mar 202410210477
Apr 202410410449
May 202411311434
Jun 202411311834
Jul 202411311658
Aug 2024919231
Sep 2024838543
Oct 20248182279
Nov 2024848728
Dec 202410411238
Jan 202510210442
Feb 202510710738
Mar 2025575732
Apr 202512612730
May 2025484936
Jun 2025444528
Jul 2025110
Aug 2025110
Jan 2026300
Total910692953475